Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
927,3 DKK | +1,13% | -0,16% | +32,83% |
31/05 | Zealand Pharma krijgt steun van EU Panel voor behandeling van ernstige hypoglykemie | MT |
30/05 | Deense overheid voert strengere subsidieregels in voor diabetesmedicijnen | MT |
ETF's gepositioneerd op Novo Nordisk A/S
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
21.31% | 200 M€ | +16,70% | ||
10.45% | 5 M€ | +15,85% | ||
5.40% | 17 M€ | +6,09% | - | |
4.67% | 88 M€ | +10,37% | - | |
3.95% | 4 M€ | -.--% | - | |
3.91% | 5 M€ | +10,09% | - | |
3.91% | 14 M€ | +5,66% | - | |
3.78% | 6 M€ | -.--% | ||
3.09% | 12 M€ | +15,09% | - | |
3.02% | 6 M€ | -.--% | - | |
2.87% | 29 M€ | +8,37% | - | |
2.53% | 3 859 M€ | +18,82% | - | |
2.53% | 469 M€ | -2,05% | ||
2.22% | 3 M€ | +9,95% | - | |
1.91% | 2 M€ | -.--% | - | |
1.91% | 2 M€ | +9,19% | - | |
1.67% | 10 M€ | -3,35% | - | |
1.60% | 10 M€ | +6,14% | - | |
1.31% | 253 M€ | +5,88% | ||
1.30% | 48 M€ | +9,22% | ||
1.21% | 17 M€ | +4,55% | ||
1.04% | 276 M€ | +11,40% | - | |
1.03% | 7 M€ | +5,36% | - | |
0.89% | 1 083 M€ | +4,80% | ||
0.79% | 284 M€ | -.--% | ||
0.76% | 786 M€ | -.--% | ||
0.76% | 23 M€ | -.--% | - | |
0.75% | 206 M€ | -.--% | ||
0.70% | 7 M€ | +0,11% | - | |
0.64% | 264 M€ | -.--% | - | |
0.64% | 187 M€ | +9,30% | - | |
0.64% | 477 M€ | +11,68% | ||
0.57% | 727 M€ | +7,40% |
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+32,83% | 598 mld. | |
+40,73% | 739 mld. | |
-6,30% | 353 mld. | |
+15,15% | 318 mld. | |
+4,05% | 285 mld. | |
+15,00% | 240 mld. | |
+9,78% | 210 mld. | |
-5,52% | 206 mld. | |
+6,17% | 164 mld. | |
-0,45% | 162 mld. |
- Beurs
- Aandelen
- Koers NOVO B
- ETF's Novo Nordisk A/S